pantoprazole has been researched along with Cardiovascular Stroke in 8 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this randomized crossover study analyzing patients after acute myocardial infarction, omeprazole coadministration showed a significant pharmacodynamic interaction with clopidogrel, whereas pantoprazole did not." | 9.15 | Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction. ( Albuquerque, A; Araújo, C; Fontes-Carvalho, R; Pimentel-Nunes, P; Ribeiro, VG, 2011) |
| "The purpose of this study was to determine the readmission rate for acute myocardial infarction (AMI) in patients discharged on clopidogrel and a proton-pump inhibitor (PPI) versus patients discharged on clopidogrel alone after experiencing an AMI and undergoing stent placement." | 7.76 | Recurrence of acute myocardial infarction in patients discharged on clopidogrel and a proton pump inhibitor after stent placement for acute myocardial infarction. ( Binkley, P; Donnally, MR; Evanchan, J; Mazzaferri, E, 2010) |
| "105 patients with ST elevation myocardial infarction (STEMI), treated with percutaneous coronary angioplasty (PCI) and who received dual antiplatelet therapy, were randomized between pantoprazole (n=54) or ranitidine (n=51)." | 5.17 | Pantoprazole significantly interferes with antiplatelet effect of clopidogrel: results of a pilot randomized trial. ( Berti, S; Della Pina, F; Dushpanova, A; Gianetti, J; Giusti, B; Marcucci, R; Parri, MS; Saracini, C, 2013) |
| "To clarify the intestinal barrier function (IBF) state of patients with acute myocardial infarction-heart failure (AMI-HF), and to compare the therapeutic effects of rhubarb and Pantoprazole (proton pump inhibitor)." | 5.16 | [Effects of rhubarb on the intestinal barrier function of patients with acute myocardial infarction-heart]. ( Mao, XB; Mao, Y; Wang, SQ, 2012) |
| "In this randomized crossover study analyzing patients after acute myocardial infarction, omeprazole coadministration showed a significant pharmacodynamic interaction with clopidogrel, whereas pantoprazole did not." | 5.15 | Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction. ( Albuquerque, A; Araújo, C; Fontes-Carvalho, R; Pimentel-Nunes, P; Ribeiro, VG, 2011) |
| "The purpose of this study was to determine the readmission rate for acute myocardial infarction (AMI) in patients discharged on clopidogrel and a proton-pump inhibitor (PPI) versus patients discharged on clopidogrel alone after experiencing an AMI and undergoing stent placement." | 3.76 | Recurrence of acute myocardial infarction in patients discharged on clopidogrel and a proton pump inhibitor after stent placement for acute myocardial infarction. ( Binkley, P; Donnally, MR; Evanchan, J; Mazzaferri, E, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brendel, K | 1 |
| Weigel, G | 1 |
| Griesmacher, A | 1 |
| Pachinger, O | 1 |
| Mair, J | 1 |
| Allen, MJ | 1 |
| McLean-Veysey, P | 1 |
| Evanchan, J | 1 |
| Donnally, MR | 1 |
| Binkley, P | 1 |
| Mazzaferri, E | 1 |
| Fontes-Carvalho, R | 1 |
| Albuquerque, A | 1 |
| Araújo, C | 1 |
| Pimentel-Nunes, P | 1 |
| Ribeiro, VG | 1 |
| Alexopoulos, D | 1 |
| Xanthopoulou, I | 1 |
| Tsigkas, G | 1 |
| Damelou, A | 1 |
| Theodoropoulos, KC | 1 |
| Kassimis, G | 1 |
| Chouchoulis, K | 1 |
| Davlouros, P | 1 |
| Chiladakis, J | 1 |
| Hahalis, G | 1 |
| Parri, MS | 1 |
| Gianetti, J | 1 |
| Dushpanova, A | 1 |
| Della Pina, F | 1 |
| Saracini, C | 1 |
| Marcucci, R | 1 |
| Giusti, B | 1 |
| Berti, S | 1 |
| Mao, XB | 1 |
| Wang, SQ | 1 |
| Mao, Y | 1 |
| Mahabaleshwarkar, RK | 1 |
| Yang, Y | 1 |
| Datar, MV | 1 |
| Bentley, JP | 1 |
| Strum, MW | 1 |
| Banahan, BF | 1 |
| Null, KD | 1 |
4 trials available for pantoprazole and Cardiovascular Stroke
| Article | Year |
|---|---|
Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Blood Platelets; Clopidogrel; Cross-Over Studies; Dru | 2011 |
Predictors of high on-treatment platelet reactivity early after clopidogrel loading in ST-elevation myocardial infarction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Blood Platelets; Clopidogrel; Female; Humans; Male; M | 2012 |
Pantoprazole significantly interferes with antiplatelet effect of clopidogrel: results of a pilot randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Clopidogrel; Drug Interactions; Female; Humans; Male; | 2013 |
[Effects of rhubarb on the intestinal barrier function of patients with acute myocardial infarction-heart].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Endotoxins; Female; Glutamine; Heart Failure; Humans; | 2012 |
4 other studies available for pantoprazole and Cardiovascular Stroke
| Article | Year |
|---|---|
Low prevalence of clopidogrel and acetylsalicylic acid resistance in patients with acute myocardial infarction and pantoprazole treatment in everyday practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Drug | 2013 |
Interaction between clopidogrel and proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Case-Control Studies; Clopidogrel; Drug Interactions; Drug | 2009 |
Recurrence of acute myocardial infarction in patients discharged on clopidogrel and a proton pump inhibitor after stent placement for acute myocardial infarction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Angioplasty, Balloon, Coronary; Anti-Ulcer Agents; Clopidog | 2010 |
Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Case-Control Studies; Clopidogrel; | 2013 |